Cambridge Health Group appoints Wael Abdallah as permanent CEO to drive regional expansion

UAE—Cambridge Health Group, the GCC’s leading post-acute care provider operating over 700 beds alongside extensive outpatient and home healthcare services, has appointed Wael Abdallah as Chief Executive Officer.

The appointment takes effect immediately, and Abdallah transitions from his interim role, which he assumed in February 2025.

Abdallah previously served as Chief Investment Officer and has maintained close involvement with Cambridge Health Group for several years.

During this time, he played a pivotal role in driving strategic development, improving operational performance, and expanding the company’s presence across key markets.

His contributions include strengthening financial results, enhancing profitability, and advancing major growth initiatives.

Strategic vision

As Chief Executive Officer, Abdallah will accelerate the company’s regional strategy, expand service offerings, and maintain high patient care standards.

His leadership focuses on operational excellence across all facilities and clinical programs.

Dr. Ali Saeed bin Harmal Aldhaheri, Chairman of Cambridge Health Group, praised Abdallah’s performance since assuming the interim position.

“Wael has demonstrated exceptional leadership, strategic clarity, and operational discipline,” Dr. Aldhaheri stated.

The Board’s decision reflects strong confidence in Abdallah’s ability to guide the organization through its next growth phase.

Dr. Aldhaheri expects Cambridge Health Group to strengthen its position as the region’s leading post-acute and rehabilitation care provider under Abdallah’s leadership.

The company plans to expand across key markets while delivering quality clinical outcomes, enhancing operational efficiency, and driving shareholder value.

Expansion plans

Abdallah expressed gratitude for the board’s trust and acknowledged the company’s strong reputation for specialized post-acute care and rehabilitation services throughout the region.

He identified significant opportunities as demand for specialized care continues rising across the GCC.

The new CEO outlined ambitious targets, including delivering more than 1,000 post-acute care beds across the region in the coming years.

Cambridge Health Group plans to simultaneously broaden its clinical services and strengthen its comprehensive care offering.

Financial performance

The appointment comes during a period of robust growth for Cambridge Health Group, which is a subsidiary of Amanat Holdings.

In 2025, the company achieved record financial results with revenue reaching AED 404 million (USD 110 million), representing an 11 per cent year-on-year increase.

EBITDA grew to AED 100 million (USD 27.2 million), marking a 14 per cent annual rise.

Management expects further double-digit growth throughout 2026.

Operational expansion continues at a pace, with capacity projected to increase from 625 beds at the end of 2025 to approximately 725 beds during 2026.

The company actively explores additional greenfield and brownfield development opportunities across the GCC region.

Cambridge Health Group’s long-term strategy encompasses expanding clinical services to include surgical procedures, hemodialysis, and comprehensive outpatient programs featuring physiotherapy and sports performance services.